Two Sigma Advisers’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-12,100
Closed -$545K 2482
2024
Q3
$545K Sell
12,100
-104,500
-90% -$4.7M ﹤0.01% 1662
2024
Q2
$4.04M Sell
116,600
-80,100
-41% -$2.78M 0.01% 859
2024
Q1
$5.69M Sell
196,700
-25,300
-11% -$732K 0.01% 728
2023
Q4
$5.09M Sell
222,000
-94,900
-30% -$2.18M 0.01% 795
2023
Q3
$5.29M Sell
316,900
-95,200
-23% -$1.59M 0.01% 702
2023
Q2
$11.4M Sell
412,100
-37,700
-8% -$1.04M 0.03% 450
2023
Q1
$10.3M Sell
449,800
-153,700
-25% -$3.54M 0.03% 544
2022
Q4
$6.58M Buy
603,500
+196,200
+48% +$2.14M 0.02% 664
2022
Q3
$3.43M Sell
407,300
-111,100
-21% -$937K 0.01% 910
2022
Q2
$4.1M Buy
518,400
+303,700
+141% +$2.4M 0.01% 862
2022
Q1
$5.08M Buy
214,700
+175,900
+453% +$4.17M 0.01% 796
2021
Q4
$1.33M Sell
38,800
-106,500
-73% -$3.64M ﹤0.01% 1406
2021
Q3
$2.58M Sell
145,300
-110,775
-43% -$1.96M 0.01% 1114
2021
Q2
$11.5M Sell
256,075
-90,600
-26% -$4.07M 0.03% 511
2021
Q1
$8.98M Sell
346,675
-20,600
-6% -$534K 0.02% 622
2020
Q4
$7.4M Buy
367,275
+12,100
+3% +$244K 0.02% 676
2020
Q3
$6.94M Sell
355,175
-64,025
-15% -$1.25M 0.02% 650
2020
Q2
$7.4M Buy
419,200
+194,500
+87% +$3.43M 0.02% 657
2020
Q1
$1.59M Sell
224,700
-94,300
-30% -$666K 0.01% 1234
2019
Q4
$2.25M Buy
319,000
+166,800
+110% +$1.18M 0.01% 1170
2019
Q3
$1.83M Buy
152,200
+27,200
+22% +$327K ﹤0.01% 1146
2019
Q2
$1.51M Buy
125,000
+31,200
+33% +$378K ﹤0.01% 1330
2019
Q1
$1.18M Sell
93,800
-2,400
-2% -$30.2K ﹤0.01% 1447
2018
Q4
$647K Sell
96,200
-46,900
-33% -$315K ﹤0.01% 1670
2018
Q3
$1.47M Sell
143,100
-14,800
-9% -$152K ﹤0.01% 1357
2018
Q2
$1.06M Buy
157,900
+110,800
+235% +$745K ﹤0.01% 1586
2018
Q1
$405K Buy
47,100
+29,700
+171% +$255K ﹤0.01% 1902
2017
Q4
$362K Buy
+17,400
New +$362K ﹤0.01% 1881